CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,000 | -40.6% | 1,270 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $32,000 | -68.6% | 1,270 | -77.6% | 0.00% | -75.0% |
| Q4 2018 | $102,000 | -43.6% | 5,670 | -8.1% | 0.00% | -20.0% |
| Q3 2018 | $181,000 | -12.6% | 6,170 | +35.6% | 0.01% | -16.7% |
| Q2 2018 | $207,000 | -11.9% | 4,550 | +2.2% | 0.01% | -25.0% |
| Q1 2018 | $235,000 | -57.0% | 4,450 | -44.7% | 0.01% | -52.9% |
| Q4 2017 | $547,000 | -17.5% | 8,050 | 0.0% | 0.02% | -22.7% |
| Q3 2017 | $663,000 | -12.1% | 8,050 | 0.0% | 0.02% | -4.3% |
| Q2 2017 | $754,000 | +72.9% | 8,050 | +17.7% | 0.02% | +76.9% |
| Q1 2017 | $436,000 | +43.4% | 6,840 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $304,000 | -58.8% | 6,840 | -14.8% | 0.01% | -67.9% |
| Q3 2015 | $738,000 | +4.5% | 8,030 | -0.6% | 0.03% | +16.7% |
| Q2 2015 | $706,000 | – | 8,081 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |